Lead sponsor
University Medical Centre Ljubljana
16 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
16
Trials led
5
Active
628
Total enrollment
3
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1/2
1
Phase 2
1
Phase 3
1
Phase 4
11
Not applicable
2
Trials by status
Not yet recruiting
1
Recruiting
3
Active, not recruiting
1
Completed
10
Unknown
1
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary SyndromeFemalePh 4Completed45
Liraglutide as Add on Therapy on Metformin in Women With Polycystic Ovary SyndromeFemalePh 4Completed40
Short Term Weight Loss With Liraglutide and Metformin in Infertile Obese PCOS PatientsFemalePh 4Completed35
Low Dose Liraglutide and Metformin vs. High Dose Liraglutide Alone in Treatment of ObesityFemalePh 4Completed30
Testosterone Replacement Therapy and Liraglutide Effects on Weight Loss in Hypogonadism.BMI ≥30Ph 4Completed30